Skip to main content
SUSMED, Inc. logo

SUSMED, Inc. — Investor Relations & Filings

Ticker · 4263 ISIN · JP3319150003 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 34 across all filing types
Latest filing 2022-02-10 Interim / Quarterly Rep…
Country JP Japan
Listing T 4263

About SUSMED, Inc.

https://www.susmed.co.jp/

SUSMED, Inc. is a research and development-oriented company that promotes digital medicine. The company's business is centered on two main areas: the development of digital therapeutics (DTx), or therapeutic applications, for various diseases such as insomnia, and the provision of clinical development support systems. These systems, which may utilize technologies like blockchain for data management, are designed to improve the efficiency of clinical trials for pharmaceutical development. The company operates under the concept of creating "sustainable medicine" through its technological solutions.

Recent filings

Filing Released Lang Actions
四半期報告書－第7期第2四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by SUSMED, Inc. with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis, and shareholding information for the second quarter of the fiscal year ending 2022. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-02-10 Japanese
訂正有価証券届出書（新規公開時）
Capital/Financing Update Classification · 95% confidence The document is a Japanese '有価証券届出書' (Securities Registration Statement), which is a formal regulatory filing submitted to the Kanto Local Finance Bureau. It details a new share issuance (IPO/public offering), underwriting terms, and the use of proceeds. This type of document is a primary regulatory filing for capital raising and does not fit into the specific categories like 10-K or Earnings Release. Therefore, it is classified as a Regulatory Filing (RNS).
2021-12-16 Japanese
訂正有価証券届出書（新規公開時）
Share Issue/Capital Change Classification · 100% confidence The document is a 'Yuka Shoken Todokesho' (Securities Registration Statement) filed with the Kanto Local Finance Bureau in Japan. It details a new share issuance (IPO/Public Offering) by SUSMED, Inc., including the number of shares, pricing methods (book-building), underwriters, and use of proceeds. This type of regulatory filing for a new share issuance falls under the 'Share Issue/Capital Change' category.
2021-12-08 Japanese
有価証券届出書（新規公開時）
Share Issue/Capital Change Classification · 100% confidence The document is a '有価証券届出書' (Securities Registration Statement) filed with the Kanto Local Finance Bureau by SUSMED, Inc. This is a formal regulatory filing required for the public offering of shares (IPO/capital increase). It contains detailed information about the offering, underwriting, and use of proceeds, which aligns with the 'Share Issue/Capital Change' category.
2021-11-19 Japanese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.